Ardena to Invest €20 Million to Expand its Advanced Nanomedicines Facility in Netherlands

Specifications:

Name:

Ardena to Invest €20 Million to Expand its Advanced Nanomedicines Facility in Netherlands

Location:

Netherlands

Company:

Ardena

Estimated Cost:

€20 Million

Source:

https://ardena.com/

Introduction:

Ardena plans to invest €20 million to expand its new analytical laboratories in its expanded nanomedicines facility.

Features:

The addition of the new 2,200m2 space, strategically positioned adjacent to current 4,000 square metres facilities, will result in a more than 50 percent expansion of the total site footprint.

The facility is equipped with advanced GMP-compliant cleanrooms, designed to bolster Ardena’s expanding nanomedicines division.

Additionally, it houses laboratories dedicated to process development and analytical tasks, GMP production areas, and warehouse amenities.

With this increased capacity, the facility is fully prepared to drive forward the progress of nanomedicine research and development, expedite the creation and production of revolutionary nanomedicine drugs, efficiently translate novel therapies from idaea to clinical implementation, and ultimately, deliver benefits to patients globally.

The facility is now operational for process development and GMP analytical tasks. Furthermore, the acquisition of the GMP licence for the new production facility is anticipated in the coming months, allowing for complete operational functionality.